Experiment 601334

Compounds isolated

Details

PropertyValue
Pharmacology
Administration routeORAL
OrganismEmpty organism
CitationHOLLANDER,P: PI-SUNYER,X: CONIFE,RF:. (1997). ACARBOSE IN THE TREATMENT OF TYPE I DIABETES.. 20(3)
Amount utilized
Compound isolated
Disease264 TYPE I DIABETICS ENTERED INTO STUDY OF CMPD IN TREATING HYPERGLYCEMIA. CMPD DECREASED POST-PRANDIAL GLUCOSE LEVELS BY 59 MG/DL AND HBA1C LEVELS BY 0.48%. SIDE EFFECTS INCLUDED FLATULENCE, DIARRHEA AND ABDOMINAL PAIN.
Dose amount150.0 MG
Number1
Qualitative resultACTIVE
AnimalHUMAN ADULT
Per unitPERSON
Dose expressionDOSE